Ani Pharmaceuticals Balance Sheet (2010-2026) | ANIP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	24.26M	15.25M	100.30M	76.91M	63.38M	56.28M	48.23M	67.76M	161.71M	193.08M	221.12M	228.60M	240.11M	144.98M	144.86M	149.80M	217.80M	262.61M	285.58M	311.18M
Short-term Investments (Quarter)			5.00M	5.00M	5.00M	5.00M	5.01M							0.04M	0.03M	0.03M	0.04M	0.04M	0.04M	0.04M
Cash & Current Investments (Quarter)	24.26M	15.25M	105.30M	81.91M	68.39M	61.28M	53.23M	67.76M	161.71M	193.08M	221.12M	228.60M	240.11M	145.02M	144.89M	149.84M	217.83M	262.65M	285.62M	311.21M
Receivables - Net (Quarter)	92.65M	106.71M	128.53M	131.62M	150.41M	140.43M	165.44M	174.71M	172.93M	178.84M	162.08M	172.42M	166.09M	196.36M	221.73M	220.33M	225.65M	252.62M	281.08M	255.43M
Receivables - Other (Quarter)							5.00M
Receivables (Quarter)	92.65M	106.71M	128.53M	131.62M	150.41M	140.43M	170.44M	174.71M	172.93M	178.84M	162.08M	172.42M	166.09M	196.36M	221.73M	220.33M	225.65M	252.62M	281.08M	255.43M
Inventory (Quarter)	73.12M	61.68M	81.69M	83.16M	100.41M	105.33M	105.36M	103.65M	104.32M	106.59M	111.20M	113.84M	125.45M	148.04M	136.78M	137.41M	138.31M	146.47M	143.07M	143.47M
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	4.88M	4.70M	7.59M	7.73M	6.03M	4.97M	8.39M	6.87M	8.25M	10.69M	17.40M	16.05M	14.00M	17.48M	17.98M	23.33M	15.11M	18.55M	34.22M	22.09M
Current Assets (Quarter)	191.80M	191.38M	321.77M	301.40M	322.40M	309.38M	344.26M	364.75M	459.31M	497.22M	519.82M	540.56M	555.46M	521.30M	528.46M	536.29M	602.63M	698.40M	753.12M	747.08M
Non-Current Assets
Buildings (Quarter)
Construction in Progress (Quarter)
Property, Plant & Equipment (Net) (Quarter)	40.33M	39.53M	52.67M	52.71M	43.77M	42.83M	43.25M	43.27M	44.37M	44.19M	44.59M	48.53M	51.64M	56.70M	56.86M	58.18M	59.25M	63.56M	62.48M	67.11M
Long-Term Investments (Quarter)
Goodwill (Quarter)	3.58M	3.58M	27.89M	28.19M	28.22M	28.22M	28.20M	28.22M	28.22M	28.22M	28.22M	28.22M	28.22M	60.43M	59.99M	60.66M	60.53M	62.48M	62.48M	62.48M
Intangibles (Quarter)	180.20M	170.14M	500.49M	281.57M	269.59M	507.49M	251.63M	238.79M	4.30M	219.83M	209.01M	196.04M	183.08M	569.83M	541.83M	538.50M	15.80M	499.82M	479.53M	467.16M
Goodwill & Intangibles (Quarter)	183.78M	173.72M	528.38M	309.76M	297.81M	535.71M	279.83M	267.01M	32.52M	248.05M	237.23M	224.26M	211.30M	630.25M	601.82M	599.16M	76.33M	562.30M	542.01M	529.64M
Long-Term Deferred Tax (Quarter)	58.53M	60.20M	67.94M	73.54M	76.59M	77.34M	81.36M	80.96M	81.50M	84.39M	90.71M	87.61M	89.51M	67.66M	85.11M	88.49M	92.03M	71.40M	69.07M	66.56M
Other Non-Current Assets (Quarter)	5.00M	5.00M	2.21M	2.43M	5.76M	12.10M	11.36M	9.23M	15.64M	16.07M	12.07M	13.57M	12.85M	11.46M	12.22M	10.31M	8.25M	12.50M	13.71M	11.57M
Non-Current Assets (Quarter)	288.36M	279.07M	449.82M	443.45M	428.94M	429.73M	415.83M	400.47M	400.03M	392.69M	384.61M	373.97M	365.29M	766.08M	756.01M	756.14M	740.37M	709.75M	687.26M	674.89M
Assets (Quarter)	480.16M	470.45M	771.60M	744.85M	751.33M	739.11M	760.09M	765.22M	859.34M	889.91M	904.42M	914.52M	920.75M	1,287.38M	1,284.47M	1,292.43M	1,343.00M	1,408.15M	1,440.38M	1,421.97M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	12.98M	11.51M	22.97M	22.06M	27.64M	18.99M	29.30M	32.69M	28.50M	34.08M	36.68M	49.43M	48.68M	60.89M	45.66M	53.06M	54.57M	69.80M	62.58M	69.69M
Notes Payables (Quarter)
Payables (Quarter)	12.98M	11.51M	22.97M	22.06M	27.64M	18.99M	29.30M	32.69M	28.50M	34.08M	36.68M	49.43M	48.68M	60.89M	45.66M	53.06M	54.57M	69.80M	62.58M	69.69M
Accumulated Expenses (Quarter)	4.69M	4.54M	7.65M	8.13M	6.29M	7.75M	10.31M	13.05M	9.88M	15.33M	5.61M	15.47M	20.36M	23.45M	37.73M	12.03M	14.76M	33.22M	37.90M	13.73M
Other Accumulated Expenses (Quarter)
Short term Debt (Quarter)	15.18M	15.93M	0.85M	0.85M	0.85M	0.85M	0.85M	0.85M	25.02M	23.94M	0.85M	0.41M	0.85M	1.28M	9.17M	0.23M	13.22M	15.24M	17.27M	19.30M
Current Taxes (Quarter)										0.59M	8.16M	11.40M			5.62M	14.19M	3.29M		2.24M	5.30M
Current Deferred Revenue (Quarter)	0.06M	0.06M	0.09M	0.12M
Total Current Liabilities (Quarter)	89.45M	84.87M	87.54M	79.53M	96.31M	81.63M	99.44M	125.83M	122.86M	134.35M	145.48M	136.89M	139.98M	189.93M	194.45M	201.81M	236.84M	270.56M	278.11M	239.51M
Non-Current Liabilities
Non-Current Debt (Quarter)	189.53M	186.06M	286.52M	286.31M	286.10M	285.88M	285.67M	285.46M	285.24M	285.03M	284.82M	284.61M	284.39M	312.92M	309.11M	305.29M	301.48M	297.68M	291.84M	286.00M
Convertible Debt (Quarter)
Preferred Stock Liabilities (Quarter)			24.85M	24.85M	24.85M	24.85M	24.85M	24.85M	24.85M	24.85M	24.85M	24.85M	24.85M	24.85M	24.85M	24.85M	24.85M
Liabilities from Discontinued Operations (Quarter)
Other Non-Current Liabilities (Quarter)	9.26M	8.12M	7.80M	32.05M	30.96M	33.43M	35.06M	13.26M	12.03M	5.26M	4.81M	11.60M	4.68M	6.94M	5.78M	7.02M	12.60M	11.38M	12.16M	8.60M
Total Non-Current Liabilities (Quarter)	278.98M	270.94M	405.06M	366.70M	383.42M	369.00M	386.49M	412.48M	412.84M	429.94M	442.01M	426.11M	435.46M	849.63M	850.16M	841.94M	868.79M	890.96M	887.49M	851.07M
Total Liabilities (Quarter)	288.24M	279.05M	412.86M	398.75M	414.38M	402.44M	421.55M	425.74M	424.87M	435.20M	446.82M	437.71M	440.14M	856.58M	855.94M	848.96M	881.39M	902.34M	899.65M	859.67M
Shareholder's Equity
Total Debt (Quarter)	204.71M	201.99M	287.37M	287.16M	286.94M	286.73M	286.52M	286.31M	310.27M	308.97M	285.67M	285.02M	285.24M	314.20M	318.28M	305.52M	314.70M	312.92M	309.11M	305.29M
Common Equity (Quarter)	191.92M	191.40M	-3.13M	0.00M	-83.63M	-4.97M	-5.09M	0.00M	0.00M	-80.88M	514.10M	523.63M	0.00M	-89.60M	0.00M	3.61M	-76.86M	505.82M	540.72M	562.30M
Shareholder's Equity (Quarter)	191.92M	191.40M	-3.13M	391.08M	-4.74M	-92.64M	403.90M	11.13M	0.00M	0.00M	0.00M	-62.33M	532.50M	510.90M	5.34M	531.05M	-76.86M	505.82M	540.72M	562.30M
Liabilities and Shareholders Equity (Quarter)	480.16M	470.45M	771.60M	744.85M	751.33M	739.11M	760.09M	765.22M	859.34M	889.91M	904.42M	914.52M	920.75M	1,287.38M	1,284.47M	1,292.43M	1,343.00M	1,408.15M	1,440.38M	1,421.97M
Treasury Shares (Quarter)	0.08M	0.63M	0.08M	0.12M	1.14M	0.15M	0.15M	0.23M	0.25M	0.26M	1.35M	0.39M	0.41M	0.16M	0.43M	0.59M	0.60M	0.61M	0.62M	0.88M
Retained Earnings (Quarter)	-5.43M	-4.24M	-3.06M	-68.30M	-83.63M	10.04M	12.17M	-96.25M	13.73M	14.08M	-80.13M	9.41M	8.33M	-89.60M	-100.28M	-85.00M	-76.86M	2.81M	1.03M	0.48M

Research Tools

Ani Pharmaceuticals Balance Sheet (2010-2026) | ANIP

Create an account

Sign In

Reset Password